Biogen Pharmachem Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.67",
    "chg": -0.1,
    "chgp": "-12.99%",
    "dir": -1,
    "prev_price": "0.77",
    "mcapval": "60.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE703D01023",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "95.92 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biogen Pharmachem Industries Stock Falls to 52-Week Low of Rs.0.73",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-stock-hits-52-week-low-amidst-weak-fundamentals-3744491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3744491.png",
        "date": "2025-12-03 15:36:40",
        "description": "Biogen Pharmachem Industries has reached a new 52-week low, with its share price touching Rs.0.73 today. This marks a significant decline over the past year, reflecting ongoing pressures within the company and the broader market environment."
      },
      {
        "title": "Biogen Pharmachem Industries Falls to 52-Week Low of Rs.0.74",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-stock-falls-to-52-week-low-of-rs074-3738350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3738350.png",
        "date": "2025-12-01 11:08:47",
        "description": "Biogen Pharmachem Industries has reached a new 52-week low of Rs.0.74, marking a significant decline in its stock price amid broader market gains. The stock has underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial performance."
      },
      {
        "title": "Why is Biogen Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biogen-pharma-fallingrising-3716106",
        "imagepath": "",
        "date": "2025-11-19 22:32:25",
        "description": "As of 19-Nov, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at Rs 0.78, which reflects a decrease of Rs 0.01 or 1.27%. The stock has underperformed significantly, with a 1-week return of -3.70% and a 1-month return of -6.02%. Additionally, it is trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 3.85% above Rs 0.75. Furthermore, there has been a notable drop in investor participation, with delivery volume falling by 13.13% compared to the 5-day average, indicating reduced interest in trading the stock.\n\nIn the broader market context, Biogen Pharma's performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, Biogen's stock has plummeted by 33.90%, while the Sensex has risen by 9.02%. ..."
      },
      {
        "title": "Biogen Pharma Faces Financial Challenges Amidst Mixed Profitability Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-financial-trend-declines-from-flat-to-negative-amid-operational-challenges-3683799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BiogenPharmache_fintrenddot_3683799.png",
        "date": "2025-11-10 08:00:12",
        "description": "Biogen Pharmachem Industries, a microcap in the NBFC sector, reported a flat performance for the quarter ending September 2025, with a decline in financial metrics. Despite a higher profit after tax of Rs 0.85 crore over six months, the company faces significant challenges, including low quarterly profit figures and a substantial stock decline."
      },
      {
        "title": "How has been the historical performance of Biogen Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-biogen-pharma-3683482",
        "imagepath": "",
        "date": "2025-11-09 22:39:21",
        "description": "Answer:\nThe historical performance of Biogen Pharma shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nBiogen Pharma's net sales have remained at zero from March 2023 to March 2025, following a modest increase to 2.47 crore in March 2022 from 1.62 crore in March 2021. Other operating income peaked at 2.38 crore in March 2024 but dropped to zero in March 2025. Total operating income followed a similar trend, reaching 2.16 crore in March 2022 before declining to zero by March 2025. The company faced a total expenditure of 1.13 crore in March 2025, a significant increase from 0.45 crore in March 2024, while operating profit (PBDIT) turned negative at -0.29 crore in March 2025, contrasting with a profit of 1.93 crore in March 2024. Profit before tax also fell to -0.29 crore in March 2025 from 1.93 crore in the previous year. The company's reserves have been negative, reaching -9..."
      }
    ],
    "total": 55,
    "sid": "200854",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.",
      "datetime": "19-Jan-2026",
      "details": "Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 3rd February 2026 inter alia to consider following businesses: - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Jan-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "20-Dec-2025",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biogen Pharmachem Industries Stock Falls to 52-Week Low of Rs.0.73

2025-12-03 15:36:40

Biogen Pharmachem Industries has reached a new 52-week low, with its share price touching Rs.0.73 today. This marks a significant decline over the past year, reflecting ongoing pressures within the company and the broader market environment.

Biogen Pharmachem Industries Falls to 52-Week Low of Rs.0.74

2025-12-01 11:08:47

Biogen Pharmachem Industries has reached a new 52-week low of Rs.0.74, marking a significant decline in its stock price amid broader market gains. The stock has underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial performance.

Why is Biogen Pharma falling/rising?

2025-11-19 22:32:25

As of 19-Nov, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at Rs 0.78, which reflects a decrease of Rs 0.01 or 1.27%. The stock has underperformed significantly, with a 1-week return of -3.70% and a 1-month return of -6.02%. Additionally, it is trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 3.85% above Rs 0.75. Furthermore, there has been a notable drop in investor participation, with delivery volume falling by 13.13% compared to the 5-day average, indicating reduced interest in trading the stock. In the broader market context, Biogen Pharma's performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, Biogen's stock has plummeted by 33.90%, while the Sensex has risen by 9.02%. ...

Biogen Pharma Faces Financial Challenges Amidst Mixed Profitability Trends

2025-11-10 08:00:12

Biogen Pharmachem Industries, a microcap in the NBFC sector, reported a flat performance for the quarter ending September 2025, with a decline in financial metrics. Despite a higher profit after tax of Rs 0.85 crore over six months, the company faces significant challenges, including low quarterly profit figures and a substantial stock decline.

How has been the historical performance of Biogen Pharma?

2025-11-09 22:39:21

Answer: The historical performance of Biogen Pharma shows significant fluctuations in its financial metrics over the years. Breakdown: Biogen Pharma's net sales have remained at zero from March 2023 to March 2025, following a modest increase to 2.47 crore in March 2022 from 1.62 crore in March 2021. Other operating income peaked at 2.38 crore in March 2024 but dropped to zero in March 2025. Total operating income followed a similar trend, reaching 2.16 crore in March 2022 before declining to zero by March 2025. The company faced a total expenditure of 1.13 crore in March 2025, a significant increase from 0.45 crore in March 2024, while operating profit (PBDIT) turned negative at -0.29 crore in March 2025, contrasting with a profit of 1.93 crore in March 2024. Profit before tax also fell to -0.29 crore in March 2025 from 1.93 crore in the previous year. The company's reserves have been negative, reaching -9...

View All News